Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for pain due to diabetic neuropathy
2006-001598-10Phase 3Completed
- Sponsor
- GW Pharmaceuticals
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic neuropathy comparing Sativex with Placebo (2 arms). Primary endpoint: Mean numeric rating scale pain score at end of treatment. Started May 2006; status: completed.
02
Drugs
cannabidiol
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on 2006-001598-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001598-10.